⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

Ipamorelin

Published Research

PubMed-indexed studies for Ipamorelin

Research

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999
View on PubMed →
Research

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.

Pharmaceutical research 1999
View on PubMed →
Research

Ipamorelin, the first selective growth hormone secretagogue.

European journal of endocrinology 1998
View on PubMed →
Research

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.

Physiology & behavior 2024
View on PubMed →
Research

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews 2026
View on PubMed →
Research

Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.

Xenobiotica; the fate of foreign compounds in biological systems 1998
View on PubMed →

Research-Grade Ipamorelin

YPB.263
Ipamorelin (10mg)
$60.00
⚠️ For laboratory research only. Not for human use.